Structure Therapeutics Inc.'s subsidiary, Aconcagua Bio, has entered into a collaboration agreement with Schrödinger, Inc. to discover and develop small molecule modulators of a specific target, with Schrödinger providing computational modeling and design support and Aconcagua providing chemistry and biology support.